Abstract
Programmed cell death (PCD) is a necessary process that helps to regulate the lifespan of lymphocytes and maintain the compartmental balance of lymphoid organs. In addition, PCD is required for the generation and maintenance of self-tolerance. Strategies that inhibit PCD cause profound alternations in the (patho)physiology of the immune system. Here, Guido Kroemer and Carlos Martínez-A. discuss the multiplicity of PCD-inducing pathways, which have been revealed through the use of PCD-inhibitory agents, and analyse the levels at which these agents act.
Original language | English |
---|---|
Pages (from-to) | 235-242 |
Number of pages | 8 |
Journal | Immunology Today |
Volume | 15 |
Issue number | 5 |
DOIs | |
Publication status | Published - 1 Jan 1994 |
Externally published | Yes |